Catalyst Funds Management Pty Ltd Invests $223,000 in Grail, Inc. (NASDAQ:GRAL)

Catalyst Funds Management Pty Ltd acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,500 shares of the company's stock, valued at approximately $223,000.

Other institutional investors have also added to or reduced their stakes in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail in the fourth quarter worth about $244,000. Moloney Securities Asset Management LLC purchased a new stake in Grail in the fourth quarter valued at approximately $559,000. Wesbanco Bank Inc. purchased a new stake in Grail in the fourth quarter valued at approximately $523,000. Rhumbline Advisers purchased a new stake in Grail in the fourth quarter valued at approximately $456,000. Finally, Slow Capital Inc. purchased a new stake in Grail in the fourth quarter valued at approximately $2,379,000.

Grail Stock Down 0.7 %

NASDAQ GRAL traded down $0.20 on Thursday, reaching $27.81. 860,919 shares of the company's stock traded hands, compared to its average volume of 1,221,654. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The stock has a 50-day simple moving average of $32.41 and a 200 day simple moving average of $21.63.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, analysts expect that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Remove Ads

Analyst Upgrades and Downgrades

Separately, Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday.

Insider Activity at Grail

In related news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Aaron Freidin sold 1,816 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at $10,457,304. This represents a 0.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock worth $360,436 over the last quarter.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.